EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel synthetic melanin as a potential anticancer agent that induces apoptosis and cyclin D downregulation through distinct pathways

Yoshiyuki Kawamoto, Yui Furuhashi, Silvi Zakiyatul Ilmiyah, Seiji Yamaguchi, Nozomi Nishimura, Riko Iwata, Arisa Imoto, Takashi Murate, Yuhsuke Ohmi, Sofy Permana, Agustina Tri Endharti, Yuki Ueno und 5 weitere

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.113065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Yoshiyuki Kawamoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan. Electronic address: ykawa@fsc.chubu.…. Hauptthemen laut MEDLINE: Apoptosis, Antineoplastic Agents, Down-Regulation, Melanins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chubu University, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite extensive development of anticancer agents, there remains a critical need for therapeutics with novel mechanisms of action. This study reports the potent anticancer activity and mechanistic analysis of highly water-soluble dopa-melanin (DM) prepared through a unique synthetic process. DM exhibits distinctive structural and chemical properties that contribute to its exceptional aqueous solubility (≥50 mg/ml) and may underlie its enhanced biological activity. DM reduced cell viability in multiple cancer cell lines. Using HeLa cells as a representative model, DM suppressed cell migration and three-dimensional growth. Fractionation revealed that activity was associated with polymers larger than 30 kDa, suggesting a critical role for high-molecular-weight species. Mechanistic studies showed that DM induced S/G2/M arrest followed by cell death with minimal apoptotic body formation. DM rapidly decreased cyclin D1 and D3 protein and mRNA levels. A pan-caspase inhibitor significantly suppressed DM's inhibitory effect on cell viability but did not prevent cyclin D degradation. Cyclin D degradation was mediated through calcium-dependent calpain activation triggered by endoplasmic reticulum Ca2+ release via IP3 receptors, and inhibition of this pathway attenuated DM's activity. In a mouse syngeneic tumor model, oral administration of DM significantly inhibited tumor growth without apparent toxicity. These results demonstrate that both caspase-dependent apoptosis and a caspase-independent cyclin D degradation pathway contribute to DM-induced cell death. Its high solubility, oral efficacy, and unique mechanism of action make DM a promising candidate for therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisAntineoplastic AgentsDown-RegulationMelaninsCyclin DHumansAnimalsMiceCell ProliferationCell SurvivalCell Line, TumorDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

anticancer drugapoptosiscalpaincyclin Dproteolysis

Substanzen

Antineoplastic AgentsMelaninsCyclin D

Autor:innen und Institutionen

  • Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan. Electronic address: ykawa@fsc.chubu.ac.jp.
  • Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan.
  • Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
  • Department of Clinical Engineering, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan.
  • Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, Malang, Indonesia.
  • Department of Clinical Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

Förderung

  • Chubu University
  • Japan Society for the Promotion of Science

Zitieren

APA

Kawamoto, Y., Furuhashi, Y., Ilmiyah, S. Z., Yamaguchi, S., Nishimura, N., Iwata, R., Imoto, A., Murate, T., Ohmi, Y., Permana, S., Endharti, A. T., Ueno, Y., Iida, M., Yajima, I., Ohgami, N., Kato, M., & Takeda, K. (2026). A novel synthetic melanin as a potential anticancer agent that induces apoptosis and cyclin D downregulation through distinct pathways. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113065

Vancouver

Kawamoto Y, Furuhashi Y, Ilmiyah SZ, Yamaguchi S, Nishimura N, Iwata R, et al. A novel synthetic melanin as a potential anticancer agent that induces apoptosis and cyclin D downregulation through distinct pathways. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113065

BibTeX
@article{Kawamoto2026,
  author = {Kawamoto, Yoshiyuki and Furuhashi, Yui and Ilmiyah, Silvi Zakiyatul and Yamaguchi, Seiji and Nishimura, Nozomi and Iwata, Riko and Imoto, Arisa and Murate, Takashi and Ohmi, Yuhsuke and Permana, Sofy and Endharti, Agustina Tri and Ueno, Yuki and Iida, Machiko and Yajima, Ichiro and Ohgami, Nobutaka and Kato, Masashi and Takeda, Kozue},
  title = {A novel synthetic melanin as a potential anticancer agent that induces apoptosis and cyclin D downregulation through distinct pathways},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.113065}
}
Kostenlos starten →